🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
ABL Bio Inc. (KOSDAQ:298380)
South Korea flag South Korea · Delayed Price · Currency is KRW
35,250
-2,600 (-6.87%)
Nov 20, 2026, 3:30 PM KST

ABL Bio Revenue

ABL Bio had revenue of 19.70B KRW in the quarter ending June 30, 2026, a decrease of -73.99%. This brings the company's total for the last twelve months to 34.28B, down -63.89% year-over-year. In the year 2025, ABL Bio had annual revenue of 79.35B with 137.55% growth. That makes ABL Bio the 32,440th largest company in the world by revenue and 2,057th in South Korea.

Revenue (ttm)
34.28B
Revenue Growth
-63.89%
P/S Ratio
57.57
Revenue / Employee
336.11M
Employees
102
Market Cap
1.97T

Revenue Chart

Revenue by Geography

  • UK 73.18B 92.2%
  • United States 5.77B 7.3%
  • South Korea 400.00M 0.5%
Fiscal year ended Dec 31, 2025 See the full ABL Bio breakdown

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202579.35B45.95B137.55%
Dec 31, 202433.40B-32.14B-49.04%
Dec 31, 202365.55B-1.75B-2.61%
Dec 31, 202267.30B61.97B1,162.19%
Dec 31, 20215.33B--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.

Related Stocks

Company NameRevenue
Chabiotech1.31T
SK bioscience690.95B
Hugel471.19B
HLB Co., Ltd.101.34B
LigaChem Biosciences71.90B
OliX Pharmaceuticals13.64B
Peptron6.00B
Kolon TissueGene4.80B
Revenue Rankings